Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
J Med Genet ; 58(6): 422-425, 2021 06.
Artigo em Inglês | MEDLINE | ID: mdl-32447322

RESUMO

Silver-Russell syndrome (SRS) is a representative imprinting disorder. A major cause is the loss of methylation (LOM) of imprinting control region 1 (ICR1) within the IGF2/H19 domain. ICR1 is a gametic differentially methylated region (DMR) consisting of two repeat blocks, with each block including three CTCF target sites (CTSs). ICR1-LOM on the paternal allele allows CTCF to bind to CTSs, resulting in IGF2 repression on the paternal allele and biallelic expression of H19 We analysed 10 differentially methylated sites (DMSs) (ie, seven CTSs and three somatic DMRs within the IGF2/H19 domain, including two IGF2-DMRs and the H19-promoter) in five SRS patients with ICR1-LOM. Four patients showed consistent hypomethylation at all DMSs; however, one exhibited a peculiar LOM pattern, showing LOM at the centromeric region of the IGF2/H19 domain but normal methylation at the telomeric region. This raised important points: there may be a separate regulation of DNA methylation for the two repeat blocks within ICR1; there is independent control of somatic DMRs under each repeat block; sufficient IGF2 repression to cause SRS phenotypes occurs by LOM only in the centromeric block; and the need for simultaneous methylation analysis of several DMSs in both blocks for a correct molecular diagnosis.


Assuntos
Centrômero/metabolismo , Metilação de DNA , Síndrome de Silver-Russell/genética , Domínio Catalítico , Criança , Pré-Escolar , Feminino , Humanos , Fator de Crescimento Insulin-Like II/genética , Masculino , Regiões Promotoras Genéticas , Sequências Reguladoras de Ácido Nucleico , Telômero/metabolismo
2.
Am J Med Genet A ; 185(10): 3062-3067, 2021 10.
Artigo em Inglês | MEDLINE | ID: mdl-34037318

RESUMO

Beckwith-Wiedemann syndrome (BWS) is an imprinting disorder caused by (epi)genetic alterations. The incidence of monozygotic (MZ) twins in BWS is higher than in the general population. Most MZ twins with BWS are female and have phenotypical discordance: one twin is clinically diagnosed with BWS, while the other shows a mild or normal phenotype. The most frequent (epi)genetic alteration in MZ twins is loss of methylation of imprinting control region 2 (ICR2-LOM) at 11p15.5. Intriguingly, ICR2-LOM is usually found in the peripheral blood leukocytes (PBL) of both twins, even if they are clinically discordant. Here, we present a rare pair of MZ dichorionic diamniotic female twins with BWS and concordant phenotypes (a Beckwith-Wiedemann spectrum score of 5 in each twin). Molecular analysis of genomic DNA from PBL revealed ICR2-LOM in one twin but not the other. Our analyses suggest that ICR2-LOM occurred between days 1 and 3 after fertilization, followed by twinning. We speculate that during embryogenesis, ICR2-LOM cells were distributed to the hematopoietic stem cells in different ratios in the two fetuses, and also to commonly affected tissues, such as the tongue, in similar ratios, although we were unable to analyze any tissues other than PBL.


Assuntos
Síndrome de Beckwith-Wiedemann/genética , Metilação de DNA/genética , Epigenômica , Síndrome de Beckwith-Wiedemann/patologia , Doenças em Gêmeos/genética , Doenças em Gêmeos/patologia , Feminino , Impressão Genômica/genética , Humanos , Masculino , Fenótipo , Gêmeos Monozigóticos/genética
3.
J Hum Genet ; 64(9): 937-943, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31235774

RESUMO

Beckwith-Wiedemann syndrome (BWS) is a representative imprinting disorder. Gain of methylation at imprinting control region 1 (ICR1-GOM), leading to the biallelic expression of IGF2 and silencing of H19, is one of the causative alterations in BWS. Twenty percent of BWS patients with ICR1-GOM have genetic defects in ICR1. Evidence of methylation anticipation in familial BWS patients with ICR1 genetic defects has been reported. However, the precise methylation pattern and extent of anticipation in these patients remain elusive. In addition, although age-related IGF2-DMR0 hypomethylation has been reported in the normal population, the period of its occurrence is unknown. In this study, we analyzed 10 sites (IGF2-DMR0, IGF2-DMR2, CTCF binding sites 1-7, and the H19 promoter) within the IGF2/H19 domain in familial BWS patients harboring a pathogenic variant in ICR1. We found that sites near the variant had relatively higher methylation in the first affected generation and observed methylation anticipation through maternal transmission in the next generation. The extent of anticipation was greater at sites far from the variant than nearby sites. The extended and severe GOM might be due to the insufficient erasure/demethylation of pre-acquired ICR1-GOM in primordial germ cells or during the preimplantation stage. In the normal population, age-related IGF2-DMR0 hypomethylation occurred; it became established by young adulthood and continued to old age. Further studies are needed to clarify (1) the precise mechanism of anticipation in patients with familial BWS and (2) the mechanism and biological significance of constitutive hypomethylation of IGF2-DMR0 and/or other imprinted differentially methylated regions.


Assuntos
Síndrome de Beckwith-Wiedemann/genética , Metilação de DNA/genética , Inativação Gênica , Fator de Crescimento Insulin-Like II/genética , Linhagem , RNA Longo não Codificante/genética , Elementos de Resposta , Adulto , Síndrome de Beckwith-Wiedemann/metabolismo , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Fator de Crescimento Insulin-Like II/biossíntese , Masculino , Pessoa de Meia-Idade , RNA Longo não Codificante/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA